US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Mira Pharma

0.7636

+0.05357.53%

Post-market: 0.7500-0.0136-1.78%19:30 EDT

Volume:117.40K

Turnover:92.91K

Market Cap:31.98M

PE:-0.53

High:0.8200

Open:0.7200

Low:0.7200

Close:0.7101

52wk High:2.45

52wk Low:0.6000

Shares:41.88M

Float Shares:34.94M

Volume Ratio:2.27

T/O Rate:0.34%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.4419

EPS(LYR):-1.3505

ROE:-217.12%

ROA:-129.55%

PB:3.92

PE(LYR):-0.57

Loading ...

Overview Company News Filings

Mira Pharmaceuticals Q2 2026 Net Loss Narrows to $1.21 Million; Revenue Remains no Revenue

Mira Pharma Reports Positive 7-Day Dog Toxicokinetic Study Results for Obesity Drug Candidate SKNY-1

MIRA Pharmaceuticals Receives Nasdaq Minimum Bid Price Notice

Mira Pharmaceuticals Risks NASDAQ Delisting After Shares Fall Below $1 Bid Price Requirement

Mira Pharmaceuticals provides update on MIRA-55, SKNY-1

Mira Pharmaceuticals Advances Mira-55 Toward IND-enabling Studies After Completing Exploratory Tox Dosing in Rats, Dogs

MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies

Mira Pharmaceuticals Announces Annual Shareholder Meeting

Mira Pharmaceuticals Oral Form Shows 'Positive' Results in Pre-Clinical Studies

MT Newswires Live

Mira Pharmaceuticals - Announces Positive Preclinical Results for Oral Mira-55 - SEC Filing

THOMSON REUTERS

Mira Pharmaceuticals Announces Release of Mira-55 Oral Formulation Update

MIRA Reports Positive Preclinical Data for SKNY-1 Program

Mira Pharmaceuticals reports SKNY-1 formulation results

Mira Pharmaceuticals - Announces Positive Preclinical Results for Oral Skny-1 - SEC Filing

THOMSON REUTERS

Mira Pharmaceuticals - Skny-1 Shows Favorable Bioavailability, Robust Brain and Liver Exposure, Once-daily Dosing Potential - SEC Filing

THOMSON REUTERS

Mira Pharmaceuticals Reports Positive Preclinical Oral Formulation Results for Obesity, Addiction Drug Candidate Skny-1

Mira Pharma Reports Preclinical Study Showing Mira-55 Reduces Anxiety-like Behavior, Differs from THC Mechanism

Mira Pharmaceuticals - Submits Phase 2a Clinical Trial Protocol to FDA for Ketamir-2 - SEC Filing

THOMSON REUTERS

Mira Pharmaceuticals submits FDA Phase 2a trial protocol for Ketamir-2 in chemotherapy-induced neuropathy

Mira Pharmaceuticals CFO Andriy Mushak files initial beneficial ownership statement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/MIRA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MIRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MIRA\",,,,,undefined,":{"symbol":"MIRA","market":"US","secType":"STK","nameCN":"Mira Pharma","latestPrice":0.7636,"timestamp":1787342400000,"preClose":0.7101,"halted":0,"volume":117396,"hourTrading":{"tag":"盘后","latestPrice":0.75,"preClose":0.7636,"latestTime":"19:30 EDT","volume":1183,"amount":888.9174,"timestamp":1787355006535,"change":-0.0136,"changeRate":-0.01781,"amplitude":0.01781},"delay":0,"changeRate":0.0753415011970145,"floatShares":34944200,"shares":41876087,"eps":-1.4419,"marketStatus":"Market Closed","change":0.0535,"latestTime":"08-21 16:00:00 EDT","open":0.72,"high":0.82,"low":0.72,"amount":92910.1293,"amplitude":0.140825,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.4419,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1691035200000,"exchange":"NASDAQ","adjPreClose":0.7101,"preHourTrading":{"tag":"盘前","latestPrice":0.73,"preClose":0.7101,"latestTime":"09:00 EDT","volume":1780,"amount":1299.053434,"timestamp":1787317257193,"change":0.0199,"changeRate":0.028024,"amplitude":0.036192},"postHourTrading":{"tag":"盘后","latestPrice":0.75,"preClose":0.7636,"latestTime":"19:30 EDT","volume":1183,"amount":888.9174,"timestamp":1787355006535,"change":-0.0136,"changeRate":-0.01781,"amplitude":0.01781},"volumeRatio":2.2679607784245994},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MIRA\",,,,,undefined,":{"symbol":"MIRA","floatShares":34944200,"roa":"-129.55%","roe":"-217.12%","lyrEps":-1.350504,"volumeRatio":2.2679607784245994,"shares":41876087,"dividePrice":0,"high":0.82,"amplitude":0.140825,"preClose":0.7101,"low":0.72,"week52Low":0.6,"pbRate":"3.92","week52High":2.45,"institutionHeld":0,"latestPrice":0.7636,"eps":-1.4419,"divideRate":0,"volume":117396,"delay":0,"ttmEps":-1.4419,"open":0.72,"prevYearClose":1.51,"prevWeekClose":0.7802,"prevMonthClose":0.792,"prevQuarterClose":0.9465,"fiveDayClose":0.7802,"twentyDayClose":0.8818,"sixtyDayClose":1.155},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MIRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"MIRA","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2026-05-14","symbol":"MIRA","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"","actualEps":-0.03},{"date":"2026-03-31","symbol":"MIRA","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774944000000,"name":null,"time":"","dateTimestamp":1774929600000,"actualEps":null},{"market":"US","date":"2025-11-13","symbol":"MIRA","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-1.18},{"market":"US","date":"2025-08-14","symbol":"MIRA","fiscalQuarterEnding":"2025/06","expectedEps":-0.11,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.09}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MIRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MIRA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MIRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MIRA","date":"2026-08-21","current":-0.529579,"percent":0.47832,"low":-15.501022,"twenty":-6.515788,"median":-2.930145,"eighty":-1.709075,"high":-0.648567,"avg":-3.991571,"sd":3.123833,"marketCap":29839883},"quantilePoints":[{"date":"2023-08-04","current":-15.501022,"twenty":-15.501022,"median":-15.501022,"eighty":-15.501022,"marketCap":109409161},{"date":"2023-08-11","current":-14.407729,"twenty":-14.826558,"median":-14.407729,"eighty":-13.088417,"marketCap":101692488},{"date":"2023-08-18","current":-13.611953,"twenty":-14.407729,"median":-13.779485,"eighty":-13.130299,"marketCap":96075752},{"date":"2023-08-25","current":-13.193124,"twenty":-14.407729,"median":-13.42348,"eighty":-13.109358,"marketCap":93119575},{"date":"2023-09-01","current":-13.137838,"twenty":-14.303022,"median":-13.371126,"eighty":-13.130299,"marketCap":92729360},{"date":"2023-09-07","current":-12.209294,"twenty":-13.9889,"median":-13.365891,"eighty":-13.071664,"marketCap":86175515},{"date":"2023-09-15","current":-7.434221,"twenty":-13.678966,"median":-13.193124,"eighty":-12.686741,"marketCap":52472141},{"date":"2023-09-22","current":-11.507289,"twenty":-13.511434,"median":-13.119829,"eighty":-11.928492,"marketCap":66366173},{"date":"2023-09-29","current":-12.263336,"twenty":-13.419292,"median":-13.046534,"eighty":-11.42538,"marketCap":70726534},{"date":"2023-10-06","current":-12.045492,"twenty":-13.402539,"median":-12.816178,"eighty":-11.507289,"marketCap":69470159},{"date":"2023-10-13","current":-7.586097,"twenty":-13.383691,"median":-12.460173,"eighty":-11.225373,"marketCap":43751419},{"date":"2023-10-20","current":-8.457473,"twenty":-13.371126,"median":-12.263336,"eighty":-10.752267,"marketCap":48776920},{"date":"2023-10-27","current":-6.022746,"twenty":-13.371126,"median":-12.209294,"eighty":-9.627991,"marketCap":34735079},{"date":"2023-11-03","current":-3.818677,"twenty":-13.36275,"median":-12.045492,"eighty":-8.098671,"marketCap":22023518},{"date":"2023-11-10","current":-3.793048,"twenty":-13.343902,"median":-11.968606,"eighty":-7.418465,"marketCap":21875709},{"date":"2023-11-17","current":-6.622011,"twenty":-13.222442,"median":-11.712319,"eighty":-5.991992,"marketCap":49959391},{"date":"2023-11-24","current":-6.405718,"twenty":-13.159952,"median":-11.404903,"eighty":-6.252529,"marketCap":48327581},{"date":"2023-12-01","current":-6.955071,"twenty":-13.133315,"median":-11.148487,"eighty":-6.405718,"marketCap":52472141},{"date":"2023-12-08","current":-3.546106,"twenty":-13.117734,"median":-10.762135,"eighty":-5.961237,"marketCap":26753401},{"date":"2023-12-15","current":-2.977946,"twenty":-13.096793,"median":-9.110163,"eighty":-5.156496,"marketCap":22466945},{"date":"2023-12-22","current":-2.066929,"twenty":-13.063287,"median":-8.611245,"eighty":-3.869935,"marketCap":15593833},{"date":"2023-12-29","current":-2.155092,"twenty":-13.025592,"median":-8.1243,"eighty":-3.839181,"marketCap":16258973},{"date":"2024-01-05","current":-2.272643,"twenty":-12.962768,"median":-7.893642,"eighty":-3.762396,"marketCap":17145826},{"date":"2024-01-12","current":-1.929591,"twenty":-12.874813,"median":-7.640782,"eighty":-3.079823,"marketCap":14557693},{"date":"2024-01-19","current":-1.608482,"twenty":-12.807801,"median":-7.444864,"eighty":-2.883906,"marketCap":12135106},{"date":"2024-01-26","current":-2.292235,"twenty":-12.642964,"median":-7.355439,"eighty":-2.366683,"marketCap":17293635},{"date":"2024-02-02","current":-1.880808,"twenty":-12.498268,"median":-7.111805,"eighty":-2.256969,"marketCap":14189649},{"date":"2024-02-09","current":-1.950359,"twenty":-12.397348,"median":-6.788541,"eighty":-2.206031,"marketCap":14714371},{"date":"2024-02-16","current":-2.01795,"twenty":-12.300188,"median":-6.405718,"eighty":-2.186439,"marketCap":15224311},{"date":"2024-02-23","current":-2.076725,"twenty":-12.241719,"median":-6.022746,"eighty":-2.135501,"marketCap":15667738},{"date":"2024-03-01","current":-1.968971,"twenty":-12.205282,"median":-5.750179,"eighty":-2.104154,"marketCap":14854789},{"date":"2024-03-08","current":-1.86102,"twenty":-12.137755,"median":-4.971969,"eighty":-2.061052,"marketCap":14040362},{"date":"2024-03-15","current":-2.409785,"twenty":-12.045492,"median":-3.957585,"eighty":-2.070847,"marketCap":18180488},{"date":"2024-03-22","current":-2.46856,"twenty":-12.014738,"median":-3.869935,"eighty":-2.084562,"marketCap":18623915},{"date":"2024-03-28","current":-2.135501,"twenty":-11.968606,"median":-3.818677,"eighty":-2.096317,"marketCap":16111164},{"date":"2024-04-05","current":-1.258227,"twenty":-11.958355,"median":-3.592948,"eighty":-2.059093,"marketCap":15076502},{"date":"2024-04-12","current":-1.209008,"twenty":-11.917349,"median":-3.095496,"eighty":-2.037542,"marketCap":14486745},{"date":"2024-04-19","current":-1.033719,"twenty":-11.835337,"median":-3.026925,"eighty":-1.978767,"marketCap":12386381},{"date":"2024-04-26","current":-1.1102,"twenty":-11.507289,"median":-2.977946,"eighty":-1.941738,"marketCap":13302796},{"date":"2024-05-03","current":-0.996589,"twenty":-11.466334,"median":-2.723253,"eighty":-1.872971,"marketCap":11941476},{"date":"2024-05-10","current":-0.925167,"twenty":-11.297339,"median":-2.546927,"eighty":-1.840684,"marketCap":11085663},{"date":"2024-05-17","current":-0.812651,"twenty":-11.251002,"median":-2.419581,"eighty":-1.782849,"marketCap":10043611},{"date":"2024-05-24","current":-1.05244,"twenty":-11.138236,"median":-2.390193,"eighty":-1.612165,"marketCap":13007178},{"date":"2024-05-31","current":-0.956764,"twenty":-11.09723,"median":-2.331418,"eighty":-1.319904,"marketCap":11824708},{"date":"2024-06-07","current":-0.922081,"twenty":-10.81147,"median":-2.30203,"eighty":-1.233679,"marketCap":11396062},{"date":"2024-06-14","current":-0.849247,"twenty":-10.732533,"median":-2.292235,"eighty":-1.18937,"marketCap":10495906},{"date":"2024-06-21","current":-0.875439,"twenty":-10.189973,"median":-2.272643,"eighty":-1.090284,"marketCap":10819607},{"date":"2024-06-28","current":-0.77737,"twenty":-9.841423,"median":-2.272643,"eighty":-1.073193,"marketCap":9607575},{"date":"2024-07-05","current":-0.687674,"twenty":-9.256415,"median":-2.262847,"eighty":-1.05424,"marketCap":8499008},{"date":"2024-07-12","current":-0.717692,"twenty":-8.841445,"median":-2.213868,"eighty":-1.045463,"marketCap":8870009},{"date":"2024-07-15","current":-0.704656,"twenty":-8.774265,"median":-2.213868,"eighty":-1.033719,"marketCap":8708897},{"date":"2024-08-02","current":-2.906169,"twenty":-8.772416,"median":-2.213868,"eighty":-1.036655,"marketCap":35917550},{"date":"2024-08-09","current":-2.535423,"twenty":-8.703509,"median":-2.262847,"eighty":-1.048424,"marketCap":31335476},{"date":"2024-08-16","current":-2.173611,"twenty":-8.390838,"median":-2.272643,"eighty":-1.04904,"marketCap":27788063},{"date":"2024-08-23","current":-2.162049,"twenty":-8.098671,"median":-2.248016,"eighty":-1.051378,"marketCap":27640254},{"date":"2024-08-30","current":-2.162049,"twenty":-7.95515,"median":-2.242981,"eighty":-1.05289,"marketCap":27640254},{"date":"2024-09-06","current":-1.826758,"twenty":-7.791127,"median":-2.23142,"eighty":-1.05469,"marketCap":23353798},{"date":"2024-09-13","current":-1.549276,"twenty":-7.650578,"median":-2.222644,"eighty":-1.05842,"marketCap":19806385},{"date":"2024-09-20","current":-1.341164,"twenty":-7.640782,"median":-2.194276,"eighty":-1.060611,"marketCap":17145826},{"date":"2024-09-27","current":-1.237108,"twenty":-7.586097,"median":-2.16783,"eighty":-1.073193,"marketCap":15815546},{"date":"2024-10-04","current":-1.352726,"twenty":-7.444864,"median":-2.155092,"eighty":-1.083185,"marketCap":17293635},{"date":"2024-10-11","current":-1.24867,"twenty":-7.434221,"median":-2.147009,"eighty":-1.095016,"marketCap":15963355},{"date":"2024-10-18","current":-1.260232,"twenty":-7.355439,"median":-2.135501,"eighty":-1.1102,"marketCap":16111164},{"date":"2024-10-25","current":-1.437761,"twenty":-7.355439,"median":-2.125705,"eighty":-1.110817,"marketCap":18380747},{"date":"2024-10-31","current":-2.79918,"twenty":-7.270245,"median":-2.125705,"eighty":-1.18937,"marketCap":35785525},{"date":"2024-11-08","current":-2.150279,"twenty":-7.139233,"median":-2.135501,"eighty":-1.21299,"marketCap":27489790},{"date":"2024-11-15","current":-2.170683,"twenty":-7.064784,"median":-2.135501,"eighty":-1.218696,"marketCap":24399222},{"date":"2024-11-22","current":-1.856409,"twenty":-6.974663,"median":-2.135501,"eighty":-1.224412,"marketCap":20866673},{"date":"2024-11-29","current":-1.90061,"twenty":-6.755235,"median":-2.115909,"eighty":-1.229612,"marketCap":21363499},{"date":"2024-12-06","current":-1.753275,"twenty":-6.551481,"median":-2.101597,"eighty":-1.233136,"marketCap":19707413},{"date":"2024-12-13","current":-1.650142,"twenty":-6.445215,"median":-2.081117,"eighty":-1.235736,"marketCap":18548154},{"date":"2024-12-20","current":-1.473341,"twenty":-6.405718,"median":-2.071827,"eighty":-1.237108,"marketCap":16560852},{"date":"2024-12-27","current":-1.768009,"twenty":-6.252529,"median":-2.060335,"eighty":-1.241733,"marketCap":19873022},{"date":"2025-01-03","current":-1.694342,"twenty":-5.991992,"median":-2.057134,"eighty":-1.250581,"marketCap":19044979},{"date":"2025-01-10","current":-1.959543,"twenty":-5.868974,"median":-2.057134,"eighty":-1.258227,"marketCap":22025933},{"date":"2025-01-17","current":-1.768009,"twenty":-5.779566,"median":-2.037542,"eighty":-1.258227,"marketCap":19873022},{"date":"2025-01-24","current":-1.664875,"twenty":-5.732546,"median":-2.035768,"eighty":-1.259831,"marketCap":18713762},{"date":"2025-01-31","current":-1.856409,"twenty":-5.367769,"median":-2.010846,"eighty":-1.260232,"marketCap":20866673},{"date":"2025-02-07","current":-1.723809,"twenty":-5.033478,"median":-1.997597,"eighty":-1.260232,"marketCap":19376196},{"date":"2025-02-14","current":-1.753275,"twenty":-4.268723,"median":-1.967235,"eighty":-1.268496,"marketCap":19707413},{"date":"2025-02-21","current":-1.635408,"twenty":-4.064306,"median":-1.959359,"eighty":-1.271301,"marketCap":18382545},{"date":"2025-02-28","current":-1.502808,"twenty":-3.940055,"median":-1.950359,"eighty":-1.271793,"marketCap":16892069},{"date":"2025-03-07","current":-1.488074,"twenty":-3.869935,"median":-1.934829,"eighty":-1.271793,"marketCap":16726460},{"date":"2025-03-14","current":-1.841676,"twenty":-3.869935,"median":-1.920187,"eighty":-1.27873,"marketCap":20701065},{"date":"2025-03-21","current":-1.797476,"twenty":-3.846869,"median":-1.893243,"eighty":-1.290292,"marketCap":20204239},{"date":"2025-03-28","current":-1.620675,"twenty":-3.823803,"median":-1.885876,"eighty":-1.294917,"marketCap":18216937},{"date":"2025-04-04","current":-1.927027,"twenty":-3.8033,"median":-1.893243,"eighty":-1.309909,"marketCap":15132288},{"date":"2025-04-11","current":-1.806267,"twenty":-3.701093,"median":-1.885876,"eighty":-1.319904,"marketCap":14183998},{"date":"2025-04-17","current":-2.291021,"twenty":-3.602316,"median":-1.885876,"eighty":-1.323783,"marketCap":17990609},{"date":"2025-04-25","current":-2.128723,"twenty":-3.467739,"median":-1.885876,"eighty":-1.330657,"marketCap":16716134},{"date":"2025-05-02","current":-2.440901,"twenty":-3.248312,"median":-1.90061,"eighty":-1.333733,"marketCap":19167565},{"date":"2025-05-09","current":-2.676427,"twenty":-3.087659,"median":-1.92061,"eighty":-1.335972,"marketCap":21017067},{"date":"2025-05-16","current":-3.015077,"twenty":-3.060231,"median":-1.929591,"eighty":-1.33782,"marketCap":23875388},{"date":"2025-05-23","current":-2.611651,"twenty":-3.060231,"median":-1.942197,"eighty":-1.340821,"marketCap":20680794},{"date":"2025-05-30","current":-2.845213,"twenty":-3.032803,"median":-1.954767,"eighty":-1.341164,"marketCap":22530296},{"date":"2025-06-06","current":-2.927246,"twenty":-3.016719,"median":-1.959543,"eighty":-1.343476,"marketCap":23179883},{"date":"2025-06-13","current":-2.649478,"twenty":-3.012039,"median":-1.970481,"eighty":-1.352726,"marketCap":20980332},{"date":"2025-06-20","current":-2.628111,"twenty":-2.999889,"median":-1.99311,"eighty":-1.352726,"marketCap":20811136},{"date":"2025-06-27","current":-2.585377,"twenty":-2.991346,"median":-2.003743,"eighty":-1.36142,"marketCap":20472743},{"date":"2025-07-03","current":-2.564011,"twenty":-2.980626,"median":-2.014046,"eighty":-1.36845,"marketCap":20303547},{"date":"2025-07-11","current":-2.564011,"twenty":-2.973678,"median":-2.023876,"eighty":-1.374721,"marketCap":20303547},{"date":"2025-07-18","current":-4.711669,"twenty":-3.002927,"median":-2.037346,"eighty":-1.385099,"marketCap":37310135},{"date":"2025-07-25","current":-4.058566,"twenty":-3.076478,"median":-2.047338,"eighty":-1.397154,"marketCap":32138433},{"date":"2025-08-01","current":-3.84864,"twenty":-3.389372,"median":-2.057134,"eighty":-1.420873,"marketCap":30476100},{"date":"2025-08-08","current":-3.195538,"twenty":-3.551253,"median":-2.064723,"eighty":-1.428551,"marketCap":25304398},{"date":"2025-08-15","current":-3.428789,"twenty":-3.546261,"median":-2.076725,"eighty":-1.436037,"marketCap":27151435},{"date":"2025-08-22","current":-3.438101,"twenty":-3.551253,"median":-2.088717,"eighty":-1.466225,"marketCap":26697041},{"date":"2025-08-29","current":-3.438101,"twenty":-3.546261,"median":-2.106877,"eighty":-1.473341,"marketCap":26697041},{"date":"2025-09-05","current":-3.388985,"twenty":-3.525507,"median":-2.115909,"eighty":-1.473341,"marketCap":26315654},{"date":"2025-09-12","current":-4.076606,"twenty":-3.546416,"median":-2.135501,"eighty":-1.477279,"marketCap":31655062},{"date":"2025-09-19","current":-3.118849,"twenty":-3.546416,"median":-2.135501,"eighty":-1.484806,"marketCap":24218030},{"date":"2025-09-26","current":-3.192522,"twenty":-3.525507,"median":-2.152685,"eighty":-1.488074,"marketCap":24790109},{"date":"2025-10-03","current":-3.290754,"twenty":-3.49704,"median":-2.155092,"eighty":-1.488074,"marketCap":25552882},{"date":"2025-10-10","current":-3.290754,"twenty":-3.487217,"median":-2.162526,"eighty":-1.49011,"marketCap":25552882},{"date":"2025-10-17","current":-4.420416,"twenty":-3.487217,"median":-2.173611,"eighty":-1.498272,"marketCap":34324767},{"date":"2025-10-24","current":-3.806469,"twenty":-3.546416,"median":-2.185002,"eighty":-1.502808,"marketCap":29557438},{"date":"2025-10-31","current":-4.424118,"twenty":-3.578069,"median":-2.201174,"eighty":-1.502808,"marketCap":34353519},{"date":"2025-11-07","current":-3.861049,"twenty":-3.670695,"median":-2.213868,"eighty":-1.502941,"marketCap":29981253},{"date":"2025-11-14","current":-3.592921,"twenty":-3.756896,"median":-2.228568,"eighty":-1.509966,"marketCap":27899222},{"date":"2025-11-21","current":-8.242291,"twenty":-3.823803,"median":-2.23142,"eighty":-1.516361,"marketCap":56532717},{"date":"2025-11-28","current":-9.035993,"twenty":-3.856085,"median":-2.234472,"eighty":-1.529328,"marketCap":61976608},{"date":"2025-12-05","current":-9.035993,"twenty":-3.871153,"median":-2.253051,"eighty":-1.547915,"marketCap":61976608},{"date":"2025-12-12","current":-8.913885,"twenty":-3.914675,"median":-2.269374,"eighty":-1.5539,"marketCap":61139087},{"date":"2025-12-19","current":-9.829695,"twenty":-4.017922,"median":-2.272643,"eighty":-1.561199,"marketCap":67420500},{"date":"2025-12-26","current":-9.646533,"twenty":-4.0559,"median":-2.289228,"eighty":-1.564688,"marketCap":66164217},{"date":"2026-01-02","current":-9.219155,"twenty":-4.092912,"median":-2.292235,"eighty":-1.576475,"marketCap":63232891},{"date":"2026-01-09","current":-9.097047,"twenty":-4.198517,"median":-2.30203,"eighty":-1.591208,"marketCap":62395369},{"date":"2026-01-16","current":-8.913885,"twenty":-4.420416,"median":-2.331418,"eighty":-1.608482,"marketCap":61139087},{"date":"2026-01-23","current":-8.791777,"twenty":-4.493832,"median":-2.353856,"eighty":-1.618236,"marketCap":60301565},{"date":"2026-01-30","current":-7.63175,"twenty":-5.033478,"median":-2.394135,"eighty":-1.620675,"marketCap":52345108},{"date":"2026-02-06","current":-6.899102,"twenty":-5.899728,"median":-2.409785,"eighty":-1.620675,"marketCap":47319978},{"date":"2026-02-13","current":-7.204372,"twenty":-6.527971,"median":-2.415958,"eighty":-1.620675,"marketCap":49413782},{"date":"2026-02-20","current":-7.357007,"twenty":-6.994254,"median":-2.434454,"eighty":-1.620675,"marketCap":50460684},{"date":"2026-02-27","current":-8.120183,"twenty":-7.204372,"median":-2.451707,"eighty":-1.624409,"marketCap":55695195},{"date":"2026-03-06","current":-7.204372,"twenty":-7.265426,"median":-2.476142,"eighty":-1.628884,"marketCap":49413782},{"date":"2026-03-13","current":-7.265426,"twenty":-7.265426,"median":-2.483724,"eighty":-1.633328,"marketCap":49832543},{"date":"2026-03-20","current":-6.227508,"twenty":-7.289848,"median":-2.50832,"eighty":-1.638966,"marketCap":42713608},{"date":"2026-03-27","current":-6.471724,"twenty":-7.265426,"median":-2.523464,"eighty":-1.64662,"marketCap":44388652},{"date":"2026-04-02","current":-6.471724,"twenty":-7.265426,"median":-2.535423,"eighty":-1.650142,"marketCap":44388652},{"date":"2026-04-10","current":-4.104629,"twenty":-7.265426,"median":-2.555697,"eighty":-1.650142,"marketCap":42862528},{"date":"2026-04-17","current":-4.225354,"twenty":-7.258834,"median":-2.564011,"eighty":-1.656035,"marketCap":44123191},{"date":"2026-04-24","current":-4.225354,"twenty":-7.231117,"median":-2.577374,"eighty":-1.664875,"marketCap":44123191},{"date":"2026-05-01","current":-4.225354,"twenty":-7.204372,"median":-2.585377,"eighty":-1.664875,"marketCap":44123191},{"date":"2026-05-08","current":-4.024146,"twenty":-7.204372,"median":-2.587897,"eighty":-1.670768,"marketCap":42022087},{"date":"2026-05-15","current":-3.923945,"twenty":-7.17995,"median":-2.606744,"eighty":-1.679608,"marketCap":40975737},{"date":"2026-05-22","current":-4.233115,"twenty":-7.130713,"median":-2.612193,"eighty":-1.679608,"marketCap":41522024},{"date":"2026-05-29","current":-4.626823,"twenty":-7.105897,"median":-2.638795,"eighty":-1.679608,"marketCap":45383853},{"date":"2026-06-05","current":-4.541141,"twenty":-7.082264,"median":-2.660161,"eighty":-1.679608,"marketCap":44543412},{"date":"2026-06-12","current":-4.112732,"twenty":-7.082264,"median":-2.670844,"eighty":-1.679608,"marketCap":40341203},{"date":"2026-06-18","current":-4.190702,"twenty":-7.082264,"median":-2.675889,"eighty":-1.679608,"marketCap":41106005},{"date":"2026-06-26","current":-3.888674,"twenty":-7.053029,"median":-2.726776,"eighty":-1.685086,"marketCap":38143448},{"date":"2026-07-02","current":-4.058324,"twenty":-6.974663,"median":-2.734945,"eighty":-1.687431,"marketCap":39807523},{"date":"2026-07-10","current":-3.941368,"twenty":-6.910296,"median":-2.756312,"eighty":-1.693077,"marketCap":38660320},{"date":"2026-07-17","current":-4.00006,"twenty":-6.87468,"median":-2.79918,"eighty":-1.694342,"marketCap":39236022},{"date":"2026-07-24","current":-3.975212,"twenty":-6.844153,"median":-2.845213,"eighty":-1.694342,"marketCap":38992294},{"date":"2026-07-31","current":-3.497107,"twenty":-6.801416,"median":-2.857082,"eighty":-1.694342,"marketCap":34302629},{"date":"2026-08-07","current":-2.905474,"twenty":-6.684004,"median":-2.866446,"eighty":-1.700426,"marketCap":28499379},{"date":"2026-08-14","current":-3.325088,"twenty":-6.568471,"median":-2.905822,"eighty":-1.707238,"marketCap":31520767},{"date":"2026-08-21","current":-3.147773,"twenty":-6.515788,"median":-2.930145,"eighty":-1.709075,"marketCap":29839883}],"updateTime":1787449828155},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MIRA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659007929","title":"Mira Pharmaceuticals Q2 2026 Net Loss Narrows to $1.21 Million; Revenue Remains no Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2659007929","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659007929?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:27","pubTimestamp":1786566434,"startTime":"0","endTime":"0","summary":"Mira Pharmaceuticals Q2 2026 net loss narrows to $1.21 million; revenue remains no revenueMira Pharmaceuticals posted a net loss of USD 1.21 million for the quarter ended June 30, 2026, narrowing from","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL9DyBgG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657636112","title":"Mira Pharma Reports Positive 7-Day Dog Toxicokinetic Study Results for Obesity Drug Candidate SKNY-1","url":"https://stock-news.laohu8.com/highlight/detail?id=2657636112","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657636112?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:02","pubTimestamp":1786017749,"startTime":"0","endTime":"0","summary":"Mira Pharma reports positive 7-day dog toxicokinetic study results for obesity drug candidate SKNY-1Mira Pharmaceuticals reported positive results from a 7-day repeated-dose Beagle dog study of SKNY-1","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL3Ftx0B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656946683","title":"MIRA Pharmaceuticals Receives Nasdaq Minimum Bid Price Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2656946683","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656946683?lang=en_us&edition=fundamental","pubTime":"2026-08-01 05:33","pubTimestamp":1785533612,"startTime":"0","endTime":"0","summary":"MIRA Pharmaceuticals, Inc. ( ($MIRA) ) has provided an update. On July 27, 2026, MIRA Pharmaceuticals received notice from Nasdaq that its common s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mira-pharmaceuticals-receives-nasdaq-minimum-bid-price-notice?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mira-pharmaceuticals-receives-nasdaq-minimum-bid-price-notice?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BK4007","LCLG","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656391125","title":"Mira Pharmaceuticals Risks NASDAQ Delisting After Shares Fall Below $1 Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2656391125","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656391125?lang=en_us&edition=fundamental","pubTime":"2026-08-01 05:01","pubTimestamp":1785531668,"startTime":"0","endTime":"0","summary":"Mira Pharmaceuticals risks Nasdaq delisting after shares fall below $1 bid price requirementMira Pharmaceuticals received a Nasdaq notice for failing to meet the $1 minimum bid price rule after 30 str","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL8blR1c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655080351","title":"Mira Pharmaceuticals provides update on MIRA-55, SKNY-1","url":"https://stock-news.laohu8.com/highlight/detail?id=2655080351","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655080351?lang=en_us&edition=fundamental","pubTime":"2026-07-30 21:36","pubTimestamp":1785418597,"startTime":"0","endTime":"0","summary":"Mira Pharmaceuticals (MIRA) announced continued advancement of its two preclinical programs, MIRA-55, an investigational oral non-opioid drug candi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mira-pharmaceuticals-provides-update-on-mira-55-skny-1-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mira-pharmaceuticals-provides-update-on-mira-55-skny-1-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655872999","title":"Mira Pharmaceuticals Advances Mira-55 Toward IND-enabling Studies After Completing Exploratory Tox Dosing in Rats, Dogs","url":"https://stock-news.laohu8.com/highlight/detail?id=2655872999","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655872999?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:08","pubTimestamp":1785413331,"startTime":"0","endTime":"0","summary":"Mira Pharmaceuticals advances MIRA-55 toward IND-enabling studies after completing exploratory tox dosing in rats, dogsMira Pharmaceuticals moved two preclinical oral candidates, MIRA-55 for chronic i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL3wHQ9G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014013.SGD","BK4007","LU2095319765.USD","BK4112","SG9999014005.SGD","BK4588","SG9999014021.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00B64PRP62.GBP","MIRA","IE00BN0W2W23.USD","BK4585","IE00BN0W2V16.EUR","LU0314104364.USD","NDAQ","IE00B3QW5Z07.USD","BCDF","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655687216","title":"MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2655687216","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655687216?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:00","pubTimestamp":1785412800,"startTime":"0","endTime":"0","summary":"Completion of 7-Day Toxicology and Pharmacokinetic Studies Advances Non-Opioid Pain Therapy and Obesity Candidate DevelopmentMIAMI, July  30, 2026  (GLOBE NEWSWIRE) -- MIRA Pharmaceuticals, Inc. (NASD","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/30/3335999/0/en/MIRA-Pharmaceuticals-Progresses-MIRA-55-and-SKNY-1-Toward-IND-Enabling-Studies.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443465.HKD","LU0149725797.USD","BK4006","LU2237443978.SGD","BK4007","LU2237443622.USD","IE00B1BXHZ80.USD","LU2746668974.SGD","MIRA","LU0170899867.USD","LU2237443549.SGD","LU0267386448.USD","IND","LU2237443382.USD","LU1363072403.SGD","IE00BFXG1179.USD","LU2237443895.HKD","DEA","CMC","LU0882574139.USD","BK4194","IE00BKVL7J92.USD","BK4223","LU0971096721.USD","LU2746668461.USD","IE00BZ1G4Q59.USD","IE00BHPRN162.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655583363","title":"Mira Pharmaceuticals Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2655583363","media":"Reuters","labels":["conferences","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655583363?lang=en_us&edition=fundamental","pubTime":"2026-07-29 05:01","pubTimestamp":1785272462,"startTime":"0","endTime":"0","summary":"Mira Pharmaceuticals announces annual shareholder meetingMira Pharmaceuticals will hold its annual shareholder meeting online on Sept. 11, 2026.Shareholders will vote on electing five directors to the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDLc0WWtZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650180181","title":"Mira Pharmaceuticals Oral Form Shows 'Positive' Results in Pre-Clinical Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2650180181","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650180181?lang=en_us&edition=fundamental","pubTime":"2026-07-10 20:33","pubTimestamp":1783686827,"startTime":"0","endTime":"0","summary":"Mira Pharmaceuticals'  oral formulation of its oral drug candidate MIRA-55 as a non-opioid therapy for chronic inflammatory pain showed \"positive\" results in pre-clinical studies, supporting its continued development, the clinical-stage company said.The objective of the study was to optimize the MIRA-55's oral formulation, the company said. The one used showed \"reproducible distribution into both brain and liver tissue\" following intake, the company added.Shares of Mira were up more than 4% in recent Friday premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650874571","title":"Mira Pharmaceuticals - Announces Positive Preclinical Results for Oral Mira-55 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2650874571","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650874571?lang=en_us&edition=fundamental","pubTime":"2026-07-10 20:03","pubTimestamp":1783684980,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nFWN43B1DQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650871921","title":"Mira Pharmaceuticals Announces Release of Mira-55 Oral Formulation Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2650871921","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650871921?lang=en_us&edition=fundamental","pubTime":"2026-07-10 20:01","pubTimestamp":1783684906,"startTime":"0","endTime":"0","summary":"Mira Pharmaceuticals Announces Release of MIRA-55 Oral Formulation UpdateMira Pharmaceuticals published a press release on July 10, 2026, reporting positive preclinical results for an optimized oral f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDLbRlbMt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649622919","title":"MIRA Reports Positive Preclinical Data for SKNY-1 Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2649622919","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649622919?lang=en_us&edition=fundamental","pubTime":"2026-07-06 21:29","pubTimestamp":1783344598,"startTime":"0","endTime":"0","summary":"MIRA Pharmaceuticals, Inc. ( ($MIRA) ) has shared an announcement. On July 6, 2026, MIRA Pharmaceuticals reported positive preclinical results for ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mira-reports-positive-preclinical-data-for-skny-1-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mira-reports-positive-preclinical-data-for-skny-1-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649624780","title":"Mira Pharmaceuticals reports SKNY-1 formulation results","url":"https://stock-news.laohu8.com/highlight/detail?id=2649624780","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649624780?lang=en_us&edition=fundamental","pubTime":"2026-07-06 21:20","pubTimestamp":1783344006,"startTime":"0","endTime":"0","summary":"MIRA Pharmaceuticals (MIRA) announced results from preclinical studies evaluating the optimized oral formulation of SKNY-1, the Company’s oral drug...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mira-pharmaceuticals-reports-skny-1-formulation-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mira-pharmaceuticals-reports-skny-1-formulation-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649624546","title":"Mira Pharmaceuticals - Announces Positive Preclinical Results for Oral Skny-1 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2649624546","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649624546?lang=en_us&edition=fundamental","pubTime":"2026-07-06 21:01","pubTimestamp":1783342901,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nFWN4380HY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649624508","title":"Mira Pharmaceuticals - Skny-1 Shows Favorable Bioavailability, Robust Brain and Liver Exposure, Once-daily Dosing Potential - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2649624508","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649624508?lang=en_us&edition=fundamental","pubTime":"2026-07-06 21:01","pubTimestamp":1783342901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nFWN4380HY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649624318","title":"Mira Pharmaceuticals Reports Positive Preclinical Oral Formulation Results for Obesity, Addiction Drug Candidate Skny-1","url":"https://stock-news.laohu8.com/highlight/detail?id=2649624318","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649624318?lang=en_us&edition=fundamental","pubTime":"2026-07-06 21:00","pubTimestamp":1783342855,"startTime":"0","endTime":"0","summary":"Mira Pharmaceuticals reports positive preclinical oral formulation results for obesity, addiction drug candidate SKNY-1Mira Pharmaceuticals reported positive preclinical formulation results for SKNY-1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL83NMf6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646870546","title":"Mira Pharma Reports Preclinical Study Showing Mira-55 Reduces Anxiety-like Behavior, Differs from THC Mechanism","url":"https://stock-news.laohu8.com/highlight/detail?id=2646870546","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646870546?lang=en_us&edition=fundamental","pubTime":"2026-06-25 20:03","pubTimestamp":1782389014,"startTime":"0","endTime":"0","summary":"Mira Pharma reports preclinical study showing Mira-55 reduces anxiety-like behavior, differs from THC mechanismMira Pharmaceuticals released new preclinical data on Mira-55, a cannabinoid analog being","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL8BNzYz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644745903","title":"Mira Pharmaceuticals - Submits Phase 2a Clinical Trial Protocol to FDA for Ketamir-2 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2644745903","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644745903?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:04","pubTimestamp":1781697871,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nFWN42O0RI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644981745","title":"Mira Pharmaceuticals submits FDA Phase 2a trial protocol for Ketamir-2 in chemotherapy-induced neuropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2644981745","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644981745?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:02","pubTimestamp":1781697737,"startTime":"0","endTime":"0","summary":"Mira Pharmaceuticals submitted an FDA Phase 2a trial protocol for Ketamir-2 to treat chemotherapy-induced peripheral neuropathy.Planned randomized, double-blind, placebo-controlled crossover study tests 300 mg, 600 mg doses in patients with persistent moderate-to-severe pain.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mira Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 17, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL6nD8FX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642049098","title":"Mira Pharmaceuticals CFO Andriy Mushak files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2642049098","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642049098?lang=en_us&edition=fundamental","pubTime":"2026-06-10 05:01","pubTimestamp":1781038870,"startTime":"0","endTime":"0","summary":"Mira Pharmaceuticals filed a Form 3 naming Andriy Mushak as chief financial officer in an initial statement of beneficial ownership dated June 2, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mira Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDLbdbNSP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":49,"code":"91000000","status":"200"}]}}